EP1753435A1 - Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittels - Google Patents
Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittelsInfo
- Publication number
- EP1753435A1 EP1753435A1 EP05763426A EP05763426A EP1753435A1 EP 1753435 A1 EP1753435 A1 EP 1753435A1 EP 05763426 A EP05763426 A EP 05763426A EP 05763426 A EP05763426 A EP 05763426A EP 1753435 A1 EP1753435 A1 EP 1753435A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hormone
- combination
- use according
- daily units
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004026669A DE102004026669A1 (de) | 2004-05-28 | 2004-05-28 | Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels |
PCT/EP2005/005764 WO2005115402A1 (de) | 2004-05-28 | 2005-05-27 | Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittels |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1753435A1 true EP1753435A1 (de) | 2007-02-21 |
Family
ID=34982562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05763426A Ceased EP1753435A1 (de) | 2004-05-28 | 2005-05-27 | Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittels |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050267081A1 (de) |
EP (1) | EP1753435A1 (de) |
AR (1) | AR049195A1 (de) |
AU (1) | AU2005247101B2 (de) |
BR (1) | BRPI0511864A (de) |
DE (1) | DE102004026669A1 (de) |
EC (1) | ECSP067030A (de) |
MX (1) | MXPA06013800A (de) |
PE (1) | PE20060402A1 (de) |
RU (1) | RU2394579C2 (de) |
WO (1) | WO2005115402A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004026671A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
DE102006003509A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Kontrazeptivum |
DE102006003508A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Arzneimittel umfassend eine Hormonkombination |
DE102006062119A1 (de) * | 2006-12-22 | 2008-06-26 | Grünenthal GmbH | Arzneimittel zur Behandlung von Hauterkrankungen |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
AU4805085A (en) * | 1984-09-05 | 1986-03-24 | Schering Aktiengesellschaft | Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels |
DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
US6511970B1 (en) * | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US6326392B1 (en) * | 1997-11-06 | 2001-12-04 | American Home Products Corporation | Anti-estrogen plus progestin containing oral contraceptives |
AU3567699A (en) * | 1998-04-17 | 1999-11-08 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
US6265393B1 (en) * | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
DE10045380A1 (de) * | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
ATE350041T1 (de) * | 2001-05-18 | 2007-01-15 | Pantarhei Bioscience Bv | Pharmaceutishe zusammensetzung für die hormonersatztherapie |
KR20050040921A (ko) * | 2002-08-15 | 2005-05-03 | 와이어쓰 | 체온조절 기능장애 치료를 위한 5HT2a 수용체의 항진제 |
JP2006525358A (ja) * | 2003-05-02 | 2006-11-09 | ドゥラメド ファーマシューティカルズ, インコーポレイテッド | 長期周期避妊養生法を利用するホルモン治療の方法 |
-
2004
- 2004-05-28 DE DE102004026669A patent/DE102004026669A1/de not_active Withdrawn
- 2004-12-10 US US11/009,361 patent/US20050267081A1/en not_active Abandoned
-
2005
- 2005-05-27 MX MXPA06013800A patent/MXPA06013800A/es active IP Right Grant
- 2005-05-27 AR ARP050102211A patent/AR049195A1/es unknown
- 2005-05-27 BR BRPI0511864-6A patent/BRPI0511864A/pt not_active Application Discontinuation
- 2005-05-27 RU RU2006145077/15A patent/RU2394579C2/ru active
- 2005-05-27 PE PE2005000595A patent/PE20060402A1/es not_active Application Discontinuation
- 2005-05-27 WO PCT/EP2005/005764 patent/WO2005115402A1/de active Application Filing
- 2005-05-27 EP EP05763426A patent/EP1753435A1/de not_active Ceased
- 2005-05-27 AU AU2005247101A patent/AU2005247101B2/en active Active
-
2006
- 2006-11-27 EC EC2006007030A patent/ECSP067030A/es unknown
Non-Patent Citations (1)
Title |
---|
BRUCKER C ET AL: "Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen", CONTRACEPTION, GERON-X, INC., LOS ALTOS, CA, US, vol. 81, no. 6, 1 June 2010 (2010-06-01), pages 501 - 509, XP027049307, ISSN: 0010-7824, [retrieved on 20100219] * |
Also Published As
Publication number | Publication date |
---|---|
WO2005115402A1 (de) | 2005-12-08 |
MXPA06013800A (es) | 2007-02-02 |
ECSP067030A (es) | 2006-12-29 |
DE102004026669A1 (de) | 2005-12-15 |
PE20060402A1 (es) | 2006-07-12 |
AU2005247101A1 (en) | 2005-12-08 |
RU2006145077A (ru) | 2008-07-10 |
AU2005247101B2 (en) | 2011-02-17 |
US20050267081A1 (en) | 2005-12-01 |
AR049195A1 (es) | 2006-07-05 |
BRPI0511864A (pt) | 2008-01-22 |
RU2394579C2 (ru) | 2010-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0499348B1 (de) | Ovulationshemmendes Mittel zur hormonalen Kontrazeption | |
DE19739916C2 (de) | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
EP2131847B1 (de) | Arzneimittel umfassend wenigstens ein gestagen | |
DE19705229C2 (de) | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
EP1753408B1 (de) | Hormonales kontrazeptivum enthaltend eine kombination aus ethinylestradiol und chlormadinonacetat | |
DE60203929T2 (de) | Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung | |
EP2393473A1 (de) | Bukkales applikationssystem, 17a-estradiol enthaltend | |
EP1758560B1 (de) | Hormonale zubereitung enthaltend eine kombination aus ethinylestradiol und chlormadinonacetat | |
DE4224534A1 (de) | Ovulationshemmendes Mittel zur hormonalen Kontrazeption | |
EP1753435A1 (de) | Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittels | |
DE102006003509A1 (de) | Kontrazeptivum | |
EP1978969B1 (de) | Hormonkombination zur linderung von menstruationszuklusabhängigen stimmungsschwankungen | |
EP2749278A1 (de) | Kombination aus einem Gestagen und einem Insulinsensitizer zur Behandlung von PCOS | |
EP2229154B1 (de) | Arzneimittel enthaltend eine kontrazeptiv wirkende hormonkombination und einen insulinsensitizer | |
DE102005056527A1 (de) | Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20061228 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: LV |
|
RAX | Requested extension states of the european patent have changed |
Extension state: LV Payment date: 20061228 |
|
17Q | First examination report despatched |
Effective date: 20080731 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: RICHTER GEDEON NYRT. |
|
APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAV | Appeal reference deleted |
Free format text: ORIGINAL CODE: EPIDOSDREFNE |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20180620 |